The Implications of the Long Non-Coding RNA NEAT1 in Non-Cancerous Diseases
AbstractLong non-coding RNAs (lncRNAs) are involved in a variety of biological and cellular processes as well as in physiologic and pathophysiologic events. This review summarizes recent literature about the role of the lncRNA nuclear enriched abundant transcript 1 (NEAT1) in non-cancerous diseases with a special focus on viral infections and neurodegenerative diseases. In contrast to its role as competing endogenous RNA (ceRNA) in carcinogenesis, NEAT1’s function in non-cancerous diseases predominantly focuses on paraspeckle-mediated effects on gene expression. This involves processes such as nuclear retention of mRNAs or sequestration of paraspeckle proteins from specific promoters, resulting in transcriptional induction or repression of genes involved in regulating the immune system or neurodegenerative processes. NEAT1 expression is aberrantly—mostly upregulated—in non-cancerous pathological conditions, indicating that it could serve as potential prognostic biomarker. Additional studies are needed to elucidate NEAT1’s capability to be a therapeutic target for non-cancerous diseases. View Full-Text
Share & Cite This Article
Prinz, F.; Kapeller, A.; Pichler, M.; Klec, C. The Implications of the Long Non-Coding RNA NEAT1 in Non-Cancerous Diseases. Int. J. Mol. Sci. 2019, 20, 627.
Prinz F, Kapeller A, Pichler M, Klec C. The Implications of the Long Non-Coding RNA NEAT1 in Non-Cancerous Diseases. International Journal of Molecular Sciences. 2019; 20(3):627.Chicago/Turabian Style
Prinz, Felix; Kapeller, Anita; Pichler, Martin; Klec, Christiane. 2019. "The Implications of the Long Non-Coding RNA NEAT1 in Non-Cancerous Diseases." Int. J. Mol. Sci. 20, no. 3: 627.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.